| Alberta Derkyi, CRNP | |
|
3404 Bitterwood Place, #i003, Laurel, MD 20724 | |
| (502) 319-0090 | |
| Not Available |
| Full Name | Alberta Derkyi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3404 Bitterwood Place, #i003, Laurel, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134622871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R206074 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alberta Derkyi, CRNP 3404 Bitterwood Place, #i003, Laurel, MD 20724 Ph: (502) 319-0090 | Alberta Derkyi, CRNP 3404 Bitterwood Place, #i003, Laurel, MD 20724 Ph: (502) 319-0090 |
News Archive
Protein Potential LLC has received support from the National Institute of Allergy and Infectious Diseases of the NIH in the form of a Phase II Small Business Innovation Research Grant. The three-year award totaling approximately $3 million will support translational research to develop a vaccine for the prevention of malaria caused by the parasite Plasmodium vivax.
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally thought.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.
› Verified 5 days ago
Judith Tangi, CRNP-PMH Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8125 Mallard Shore Dr, Laurel, MD 20724 Phone: 240-838-4012 | |
Ms. Gloria Asiamah Fosu, RN, MSN, PMHMP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 14502 Greenview Dr Suit 455, Laurel, MD 20708 Phone: 240-752-4513 | |
Mrs. Bodil Lynn Morris, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13801 Belle Chasse Blvd, Unit 211, Laurel, MD 20707 Phone: 407-232-5062 | |
Ms. Florence A Nwana, CRNP-PMH Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13639 Baltimore Ave, Laurel, MD 20707 Phone: 301-604-4830 Fax: 301-604-4929 | |
Making Mpaka, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 16305 Gales Ct, Laurel, MD 20707 Phone: 301-404-0726 | |
Akukeng Mba, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13208 Deerfield Rd, Laurel, MD 20708 Phone: 301-793-4761 | |
Bolanle Akinrebiyo, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10133 Summer Glow Walk, Laurel, MD 20723 Phone: 202-631-7228 |